Artificial Intelligence (AI)
American Hospital Association resources on artificial intelligence (AI) and machine learning, their impact on the health care field, and AI and machine learning innovation in hospitals and health systems.
The Department of Health and Human Services announced Sept. 30 that it is doubling its funding for childhood cancer research from $50 million to $100 million to accelerate the development of diagnostics, treatments and prevention measures that include the use of artificial intelligence.
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial intelligence-enabled medical device performance in real-world applications. This includes approaches to detect, assess and mitigate performance…
The Office of Science and Technology Policy issued a request for information Sept. 26 seeking feedback on federal regulations that hinder AI development, deployment, or adoption.
In this Leadership Dialogue, I’m joined by Jackie Gerhart, M.D., chief medical officer of Epic and a practicing family medicine physician.
In this Leadership Dialogue conversation, Tina Freese Decker, president and CEO of Corewell Health and 2025 AHA board chair, is joined by Jackie Gerhart, M.D., chief medical officer of Epic and a practicing family medicine physician.
Deploy automation and AI tools to align workforce, care delivery and revenue cycle for agile, people-first health care systems that improve outcomes.
The Artificial Intelligence Center of Excellence is a systemwide initiative of RWJBarnabas Health and Rutgers Health dedicated to the responsible development and integration of artificial intelligence in healthcare.
The Joint Commission and the Coalition for Health AI released guidance Sept. 17 on the responsible use of artificial intelligence in health care, the first installment from their partnership that launched in June.
Prevent costly denials with AI-driven front-end tech and CDI tools to catch errors early and apply real-time payer strategies to boost outcomes.
Health care leaders may want to keep a closer eye on clinical validation for artificial intelligence (AI)-enabled medical devices (AIMDs), based on a recent JAMA Health Forum study.